Canadian Drug Use Database: Privacy Concerns

29 September 1996

Fears are growing in Canada over privacy issues following the announcement that a number of the country's largest drugstore chains are to pool their computer systems to create a nationwide private database.

Next month Rx Canada, a profit-making company, will begin coordinating the data, which it hopes to sell to pharmacies, provincial health ministries, consultants and drug plan insurers. Commercial sales of such data are illegal in provinces such as Quebec, but Rx Canada's organizers say that while individual privacy has to be protected, they do not yet have a blueprint. "That is a primary mandate for this fall's activity," said a spokesman.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight